用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
TEVA PHARMACEUTICAL INDUSTRIES LTD(9)
Teva Pharmaceutical Industries Ltd.(5)
NOVARTIS AG(2)
Teva Pharmaceuticals Usa, Inc.(1)
JIANGSU INST NUCLEAR MEDICINE(1)
WANG HONG(1)
PARK BAE KEUN [KR](1)
METACINE INC [KR](1)
GRANDSOUL MENEKI KENKYUSHO KK(1)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Zoledronate'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
下页
尾页
共
23
条记录, 当前第1/3页。
公开号
公开日
申请号
申请日
1.
KR101270467B1
2013/6/3
KR20120112030
2012/10/9
专利标题
:PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES COMPRISING BISPHOSPHONATE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS AN ACTIVE INGREDIENT
专利权人
:
PARK BAE KEUN [KR]
;
METACINE INC [KR]
;
PURPOSE: A bisphosphonate compound is provided to suppress bond of PTP-1B(Protein Tyrosine Phosphate 1B) and IR(Insulin Receptor), to treat insulin secretion in pancreatic islet, and to be used as a preventive and therapeutic agent for type 2 diabetes. CONSTITUTION: A pharmaceutical composition for preventing or treating diabetes contains zoledronate or a pharmaceutically acceptable salt thereof as an active ingredient. The diabetes is type 2 diabetes. Zoledronate or a pharmaceutically acceptabl...
2.
JP2012205581A
2012/10/25
JP20110076000
2011/3/30
专利标题
:METHOD FOR PRODUCING MHC NON-RESTRICTIVE CYTOTOXIC CELL
专利权人
:
GRANDSOUL MENEKI KENKYUSHO KK
;
PROBLEM TO BE SOLVED: To efficiently culture MHC non-restrictive cytotoxic cells such as NK cells.
3.
JP2012162531A
2012/8/30
JP20120053573
2012/3/9
专利标题
:USE OF ZOLEDRONATE FOR PRODUCING CHEMICALS FOR TREATMENT OF METABOLIC BONE DISEASE
专利权人
:
NOVARTIS AG
;
PROBLEM TO BE SOLVED: To provide chemicals for metabolic bone disease such as hypercalcaemia caused by cancer, metastatic bone tumor or multiple myeloma.
4.
CN102603812A
2012/7/25
CN2012161319
2012/3/9
专利标题
:Binuclear platinum (II)-zoledronate complex and preparation and application thereof
专利权人
:
JIANGSU INST NUCLEAR MEDICINE
;
5.
US7687636B2
2010/3/30
专利标题
:Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
专利权人
:
TEVA PHARMACEUTICAL INDUSTRIES LTD
;
The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts amorphous zoledronate sodium salt processes for making the polymorphs and amorphous zoledronate sodium salt and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
6.
US7589211B2
2009/9/15
专利标题
:Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
专利权人
:
TEVA PHARMACEUTICAL INDUSTRIES LTD
;
The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts amorphous zoledronate sodium salt processes for making the polymorphs and amorphous zoledronate sodium salt and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
7.
US7582768B2
2009/9/1
专利标题
:Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
专利权人
:
TEVA PHARMACEUTICAL INDUSTRIES LTD
;
The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts amorphous zoledronate sodium salt processes for making the polymorphs and amorphous zoledronate sodium salt and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
8.
EP1567533B1
2009/3/11
专利标题
:Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
专利权人
:
Teva Pharmaceutical Industries Ltd.
;
The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts amorphous zoledronate sodium salt processes for making the polymorphs and amorphous zoledronate sodium salt and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
9.
US7435827B2
2008/10/14
专利标题
:Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation
专利权人
:
TEVA PHARMACEUTICAL INDUSTRIES LTD
;
The invention relates to polymorphs of zoledronic acid and zoledronate sodium salts amorphous zoledronate sodium salt processes for making the polymorphs and amorphous zoledronate sodium salt and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt.
10.
CN101259133A
2008/9/10
专利标题
:Zoledronate is used to prepare the medicine of prevention and treatment osteoporosis
专利权人
:
WANG HONG
;
首页
1
2
3
下页
尾页
共
23
条记录, 当前第1/3页。
当前查询条件: [药品] 包含 'Zoledronate'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文